Trump’s Plan to Lower Drug Prices Diverges From Campaign Promise

Sharing is caring!

Ronny Gal, a securities analyst at Sanford C. Bernstein & Company, said the president’s speech was “very, very positive to pharma,” and he added, “We have not seen anything about that speech which should concern investors” in the pharmaceutical industry.

I believe there’s something to be said here about where the President’s loyalty lies. Is he a friend of big business, who will make sure not to interfere with big business or is he looking out for consumers?

Pretty obvious to me, he’ll be an ally of big business and while trying to sell us on the idea that he’s looking out for the consumer.

Source: Trump’s Plan to Lower Drug Prices Diverges From Campaign Promise – The New York Times